EUCTR2005‐005499‐34.
Methods | Allocation: randomised. Location: multi‐centre. |
Participants | Diagnosis: stable schizophrenia. |
Interventions | 1, Bifeprunox (not marketed drug) 2. Quetiapine 3. Placebo |
Outcomes | Standard efficacy, safety and tolerability measures. |
Notes | Prematurely ended, no data available. We were not able to find further information. |